{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T16:23:38Z","timestamp":1785515018791,"version":"3.56.0"},"reference-count":38,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2015,3,18]],"date-time":"2015-03-18T00:00:00Z","timestamp":1426636800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0119708","type":"journal-article","created":{"date-parts":[[2015,3,18]],"date-time":"2015-03-18T16:28:40Z","timestamp":1426696120000},"page":"e0119708","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":42,"title":["Anti-Angiogenic Effect of Metformin in Mouse Oxygen-Induced Retinopathy Is Mediated by Reducing Levels of the Vascular Endothelial Growth Factor Receptor Flk-1"],"prefix":"10.1371","volume":"10","author":[{"given":"Soo Geun","family":"Joe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Hee","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeong A","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae-Young","family":"Koh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2015,3,18]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1146\/annurev.cb.11.110195.000445","article-title":"Vasculogenesis","volume":"11","author":"W Risau","year":"1995","journal-title":"Annu Rev Cell Dev Biol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ophtha.2012.07.038","article-title":"Vascular endothelial growth factor a in intraocular vascular disease","volume":"120","author":"JW Miller","year":"2013","journal-title":"Ophthalmology"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/CS20120588","article-title":"Advances in our understanding of diabetic retinopathy","volume":"125","author":"AW Stitt","year":"2013","journal-title":"Clin Sci (Lond)"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1056\/NEJMra1005073","article-title":"Diabetic retinopathy","volume":"366","author":"DA Antonetti","year":"2012","journal-title":"N Engl J Med"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"32","DOI":"10.2174\/157339912798829188","article-title":"Diabetic retinopathy: current and new treatment options","volume":"8","author":"GP Giuliari","year":"2012","journal-title":"Curr Diabetes Rev"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1056\/NEJMoa1007374","article-title":"Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity","volume":"364","author":"HA Mintz-Hittner","year":"2011","journal-title":"N Engl J Med"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.ajo.2009.05.031","article-title":"A systematic analysis of the off-label use of bevacizumab for severe retinopathy of prematurity","volume":"148","author":"JA Micieli","year":"2009","journal-title":"Am J Ophthalmol"},{"key":"ref8","first-page":"101","article-title":"Oxygen-induced retinopathy in the mouse","volume":"35","author":"LE Smith","year":"1994","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1038\/nprot.2009.187","article-title":"Quantification of oxygen-induced retinopathy in the mouse: a model of vessel loss, vessel regrowth and pathological angiogenesis","volume":"4","author":"KM Connor","year":"2009","journal-title":"Nat Protoc"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1042\/CS20110386","article-title":"Cellular and molecular mechanisms of metformin: an overview","volume":"122","author":"B Viollet","year":"2012","journal-title":"Clin Sci (Lond)"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/S0140-6736(98)07037-8","article-title":"Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)","volume":"352","year":"1998","journal-title":"Lancet"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1093\/carcin\/bgu001","article-title":"Paradoxic effects of metformin on endothelial cells and angiogenesis","volume":"35","author":"K Dallaglio","year":"2014","journal-title":"Carcinogenesis"},{"key":"ref13","first-page":"1873","article-title":"Luteinizing hormone facilitates angiogenesis in ovarian epithelial tumor cells and metformin inhibits the effect through the mTOR signaling pathway","volume":"27","author":"H Liao","year":"2012","journal-title":"Oncol Rep"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.biopha.2009.08.004","article-title":"Metformin inhibits inflammatory angiogenesis in a murine sponge model","volume":"64","author":"DO Xavier","year":"2010","journal-title":"Biomed Pharmacother"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1093\/cvr\/cvp131","article-title":"Metformin decreases angiogenesis via NF-kappaB and Erk1\/2\/Erk5 pathways by increasing the antiangiogenic thrombospondin-1","volume":"83","author":"BK Tan","year":"2009","journal-title":"Cardiovasc Res"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.3892\/mmr.2012.753","article-title":"Effect of metformin on the proliferation, migration, and MMP-2 and -9 expression of human umbilical vein endothelial cells","volume":"5","author":"N Esfahanian","year":"2012","journal-title":"Mol Med Rep"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s10549-008-9916-5","article-title":"Therapeutic metformin\/AMPK activation promotes the angiogenic phenotype in the ERalpha negative MDA-MB-435 breast cancer model","volume":"113","author":"KN Phoenix","year":"2009","journal-title":"Breast Cancer Res Treat"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s10549-008-0016-3","article-title":"Therapeutic metformin\/AMPK activation promotes the angiogenic phenotype in the ERalpha negative MDA-MB-435 breast cancer model","volume":"114","author":"SM Hadad","year":"2009","journal-title":"Breast Cancer Res Treat"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1158\/2159-8290.CD-11-0280","article-title":"Metformin accelerates the growth of BRAF V600E-driven melanoma by upregulating VEGF-A","volume":"2","author":"MJ Martin","year":"2012","journal-title":"Cancer Discov"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1076\/ceyr.18.1.20.5390","article-title":"Diltiazem reduces retinal neovascularization in a mouse model of oxygen induced retinopathy","volume":"18","author":"RD Higgins","year":"1999","journal-title":"Curr Eye Res"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1016\/j.cellsig.2007.05.013","article-title":"Vascular endothelial growth factor receptor-2: structure, function, intracellular signalling and therapeutic inhibition","volume":"19","author":"K Holmes","year":"2007","journal-title":"Cell Signal"},{"key":"ref22","unstructured":"Munie M, ryu C, Noorulla S, Rana S, Malach D, Qiao X, et al. Effect of Metformin on the Development and Severity of Diabetic Retinopathy. 2014 The Association for Research in Vision and Ophthalmology. 2014 May 4\u20138; Orlando, Fla., USA: Thomson Reuters; 2014.(55) p.1069."},{"key":"ref23","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1593\/neo.11148","article-title":"Metformin suppresses ovarian cancer growth and metastasis with enhancement of cisplatin cytotoxicity in vivo","volume":"13","author":"R Rattan","year":"2011","journal-title":"Neoplasia"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"903","DOI":"10.3892\/or.2012.1890","article-title":"Metformin inhibits the development and metastasis of ovarian cancer","volume":"28","author":"B Wu","year":"2012","journal-title":"Oncol Rep"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1159\/000330174","article-title":"Understanding retinopathy of prematurity: update on pathogenesis","volume":"100","author":"JC Rivera","year":"2011","journal-title":"Neonatology"},{"key":"ref26","first-page":"343560","article-title":"Pathophysiology of Diabetic Retinopathy","volume":"2013","author":"JM Tarr","year":"2013","journal-title":"ISRN Ophthalmol"},{"key":"ref27","first-page":"203ra127","article-title":"Angiopoietin-1 guides directional angiogenesis through integrin alphavbeta5 signaling for recovery of ischemic retinopathy","volume":"5","author":"J Lee","year":"2013","journal-title":"Sci Transl Med"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"25130","DOI":"10.1074\/jbc.274.35.25130","article-title":"Vascular endothelial growth factor signals endothelial cell production of nitric oxide and prostacyclin through flk-1\/KDR activation of c-Src","volume":"274","author":"H He","year":"1999","journal-title":"J Biol Chem"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4062\/biomolther.2013.113","article-title":"VEGF-VEGFR Signals in Health and Disease","volume":"22","author":"M Shibuya","year":"2014","journal-title":"Biomol Ther (Seoul)"},{"key":"ref30","first-page":"967","article-title":"A review of thiazolidinediones and metformin in the treatment of type 2 diabetes with focus on cardiovascular complications","volume":"3","author":"B Molavi","year":"2007","journal-title":"Vasc Health Risk Manag"},{"key":"ref31","first-page":"317","article-title":"Managing lipid metabolism in proliferating cells: New perspective for metformin usage in cancer therapy","volume":"1845","author":"Barbato D Lettieri","year":"2014","journal-title":"Biochim Biophys Acta"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1093\/carcin\/bgt307","article-title":"Metformin targets c-MYC oncogene to prevent prostate cancer","volume":"34","author":"T Akinyeke","year":"2013","journal-title":"Carcinogenesis"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/978-3-642-38007-5_21","article-title":"New perspective for an old antidiabetic drug: metformin as anticancer agent","volume":"159","author":"A Leone","year":"2014","journal-title":"Cancer Treat Res"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s11010-013-1845-x","article-title":"Metformin reverses multidrug resistance and epithelial-mesenchymal transition (EMT) via activating AMP-activated protein kinase (AMPK) in human breast cancer cells","volume":"386","author":"C Qu","year":"2014","journal-title":"Mol Cell Biochem"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1053\/j.gastro.2009.04.013","article-title":"Antidiabetic therapies affect risk of pancreatic cancer","volume":"137","author":"D Li","year":"2009","journal-title":"Gastroenterology"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1136\/bmj.38415.708634.F7","article-title":"Metformin and reduced risk of cancer in diabetic patients","volume":"330","author":"JM Evans","year":"2005","journal-title":"BMJ"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.2337\/dc08-2175","article-title":"New users of metformin are at low risk of incident cancer: a cohort study among people with type 2 diabetes","volume":"32","author":"G Libby","year":"2009","journal-title":"Diabetes Care"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.diabres.2008.02.006","article-title":"The effect of metformin treatment on VEGF and PAI-1 levels in obese type 2 diabetic patients","volume":"81","author":"C Ersoy","year":"2008","journal-title":"Diabetes Res Clin Pract"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0119708","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,21]],"date-time":"2019-08-21T23:50:54Z","timestamp":1566431454000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0119708"}},"subtitle":[],"editor":[{"given":"Stefano L","family":"Sensi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,3,18]]},"references-count":38,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2015,3,18]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0119708","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,18]]}}}